MULTICENTER, PROSPECTIVE TRIAL OF NON-ENDOSCOPIC BIOMARKER-DRIVEN DETECTION OF BARRETT'S ESOPHAGUS AND ESOPHAGEAL ADENOCARCINOMA.
Helen R MoinovaSuman VermaJohn DumotAshley L FaulxPrasad G IyerMarcia Irene CantoJean S WangNicholas J ShaheenPrashanthi N ThotaLishan AklogJoseph E WillisSanford D MarkowitzAmitabh ChakPublished in: The American journal of gastroenterology (2024)
EsoCheck/EsoGuard demonstrated high sensitivity and specificity in detecting BE and BE-related neoplasia.